Daniel J. O'Connor, Director at SEELOS THERAPEUTICS, INC. (SEEL), bought 16,000 shares at $0.61 ($10K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
Open-market purchase of $10k SEEL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ONCS | SELL | 2021-02-02 | $26K | — | Filing → |
| ONCS | SELL | 2020-11-03 | $12K | — | Filing → |
| ONCS | SELL | 2020-08-04 | $13K | — | Filing → |